Alastair Compston

Alastair Compston
FRCP, FMedSci, FRS, CBE
Born (1948-01-23) 23 January 1948
Fields neurology
Institutions
Alma mater
Thesis Multiple sclerosis and the HLA system (1978)
Website
www.neuroscience.cam.ac.uk/directory/profile.php?AlastairCompston

(David) Alastair (Standish) Compston (born 23 January 1948)[1] FRCP, FMedSci, FRS[2] is Professor Emeritus of Neurology in the Department Of Clinical Neurosciences at the University of Cambridge and an Emeritus Fellow of Jesus College, Cambridge.[3][4]

Education

Compston was educated at Rugby School followed by Middlesex Hospital Medical School where he was awarded a Bachelor of Medicine, Bachelor of Surgery degree. He completed his PhD on multiple sclerosis and the Human Leukocyte Antigen (HLA) system at the University of London graduating in 1978.[5]

Research and career

Compston’s research focuses on the clinical science of human demyelinating disease including the discovery of genetic risk factors for multiple sclerosis and the introduction of alemtuzumab.[6][7][8] [9]

Compston was formerly Professor of Neurology at the University of Wales, president of the European Neurological Society and the Association of British Neurologists, and editor of the journal Brain.[2][10]

Awards and honours

Compston's work has been recognised by prizes including the Charcot Award; the K-J Zülch Prize; the World Federation of Neurology Medal; the John Dystel Prize; the Richard and Mary Cave Award of the Multiple Sclerosis Society of Great Britain; the Hughlings Jackson Medal; the Galen Medal; and the Association of British Neurologists Medal.[2]

Compston was elected a Fellow of the Royal Society (FRS) in 2016[2] and appointed Commander of the Order of the British Empire (CBE) in the 2016 New Year Honours.[11] He was elected a Fellow of the Academy of Medical Sciences; a Foreign Member of the National Academy of Sciences of Germany and the National Academy of Medicine of the US.

References

  1. ↑ COMPSTON, Prof. (David) Alastair (Standish). Who's Who. 2016 (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc. (subscription required)
  2. 1 2 3 4 "Professor Alastair Compston FRS". London: Royal Society. Archived from the original on 2016-04-29. One or more of the preceding sentences incorporates text from the royalsociety.org website where:
    “All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License.” --"Royal Society Terms, conditions and policies". Archived from the original on 2015-09-25. Retrieved 2016-03-09.
  3. ↑ "Professor Alastair Compston, Cambridge Neurosciene". Cambridge: cam.ac.uk. Archived from the original on 2015-03-04.
  4. ↑ "Prof Alastair Compston, CBE Authorised Biography". Debrett's. Archived from the original on 2016-05-20.
  5. ↑ Compston, David Alistair Standish (1978). Multiple sclerosis and the HLA system (PhD thesis). University of London. OCLC 500408475.
  6. ↑ Jones, Joanne L.; Phuah, Chia-Ling; Cox, Amanda L.; Thompson, Sara A.; Ban, Maria; Shawcross, Jacqueline; Walton, Amie; Sawcer, Stephen J.; Compston, Alastair; Coles, Alasdair J. (2009). "IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)". Journal of Clinical Investigation. 119: 2052–61. doi:10.1172/JCI37878. PMC 2701868Freely accessible. PMID 19546505.
  7. ↑ The CAMMS223 Trial Investigators (2008). "Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis". New England Journal of Medicine. 359 (17): 1786–1801. doi:10.1056/NEJMoa0802670.
  8. ↑ The International Multiple Sclerosis Genetics Consortium (2007). "Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study". New England Journal of Medicine. 357 (9): 851–862. doi:10.1056/NEJMoa073493.
  9. ↑ Alastair Compston's publications indexed by the Scopus bibliographic database, a service provided by Elsevier. (subscription required)
  10. ↑ Compston, Alastair (2004). "Editorial". Brain. 127 (8): 1689–1690,. doi:10.1093/brain/awh240.
  11. ↑ The London Gazette: (Supplement) no. 61450. p. N8. 2015-12-30.


This article is issued from Wikipedia - version of the 10/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.